Description
BNP REAGENT
First action · last action
2014-08-20 · 2014-08-20
Transactions
1
First transaction's obligation
$168,925
Base + all options value (sum of deltas)
$168,925
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797P5076B
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-08-20+$168,925= $168,925
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-08-20 | +$168,925 | $168,925 | BNP REAGENT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P782RNU1NNK3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0699 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $82,304 | FY2026 |
| 36C24426N0511 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2026 |
| 36C25526N0126 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $54,108 | FY2026 |
| 36C24126N0170 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $123,000 | FY2026 |
| 36C24226N0185 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24425N0741 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2025 |
Other recipients under 6550 from 693-WILKES-BARRE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415F0177 | CARDINAL HEALTH 200, LLC | 693-WILKES-BARRE | $22,521 | FY2015 |
| VA24415F0134 | IMPERIAL CONSULTING, L.L.C. | 693-WILKES-BARRE | $2,881 | FY2015 |
| VA24414J3281 | ROCHE DIAGNOSTICS CORPORATION | 693-WILKES-BARRE | $52,446 | FY2014 |
| VA24414J3066 | CEPHEID | 693-WILKES-BARRE | $191,032 | FY2014 |
| VA69312P0127 | REMEL INC. | 693-WILKES-BARRE | $5,495 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414J2383_3600_V797P5076B_3600 · retrieved 2026-09-26.